Literature DB >> 24342478

A multicenter performance evaluation of the DPP(®) HIV-1/2 assay for the detection of HIV antibodies in various HIV testing algorithms.

Jillian M Cappello1, Angelo Gunasekera2, Dhammika Gunasekera2, Javan Esfandiari2, Thomas Ippolito2.   

Abstract

BACKGROUND: Multicenter studies were conducted to evaluate the DPP(®) HIV 1/2 Assay using oral fluid (OF) and fingerstick (FS) specimens in two different countries at the point of care (POC).
OBJECTIVE: To evaluate the DPP(®) HIV 1/2 Assay using OF and FS specimens when compared to various worldwide algorithms for the detection of HIV.
METHODS: At each testing center, each participant was tested using the DPP HIV 1/2 Assay using OF and FS specimens. Each sample was dispersed into a premeasured buffer in a dropper bottle (DPP(®) SampleTainer™ bottle) and added to the sample well of the device followed by the addition of running buffer to the buffer well of the device. Reference testing was performed according to the National testing algorithm of each Country.
RESULTS: Assay sensitivity resulted in ranges of 98.9-100% for OF specimens and 99.8-100% for FS specimens. Assay specificity resulted in ranges of 99.9-100% for OF specimens and 99.5-100% for FS specimens.
CONCLUSIONS: Assay sensitivity and specificity obtained for both FS and OF were similar. The DPP HIV 1/2 Assay is highly accurate in detecting antibodies to HIV-1/2 with OF and FS specimens when compared to nationally accepted algorithms. The assay is especially advantageous in that the original sample is collected in a closed vial, eliminating the need for recollection of samples at the POC in the event of an invalid result or assay error upon testing.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DPP HIV 1/2 Assay; Fingerstick; HIV; Oral fluid; Rapid test

Mesh:

Substances:

Year:  2013        PMID: 24342478     DOI: 10.1016/j.jcv.2013.08.032

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  4 in total

1.  Evaluation of the performances of six commercial kits designed for dengue NS1 and anti-dengue IgM, IgG and IgA detection in urine and saliva clinical specimens.

Authors:  Anne-Claire Andries; Veasna Duong; Sivuth Ong; Sopheaktra Ros; Anavaj Sakuntabhai; Paul Horwood; Philippe Dussart; Philippe Buchy
Journal:  BMC Infect Dis       Date:  2016-05-16       Impact factor: 3.090

2.  Point-of-care HIV tests done by peers, Brazil.

Authors:  Ana Roberta Pati Pascom; Clarissa Habckost Dutra de Barros; Tainah Dourado de Miranda Lobo; Elisiane Nelcina Pasini; Regina Aparecida Comparini; Fábio Caldas de Mesquita
Journal:  Bull World Health Organ       Date:  2016-06-02       Impact factor: 9.408

3.  Evaluation of Blood-Based Antibody Rapid Testing for HIV Early Therapy: A Meta-Analysis of the Evidence.

Authors:  Xiaojie Huang; Xinchao Liu; Jieqing Chen; Yugang Bao; Jianhua Hou; Xiaofan Lu; Wei Xia; Huan Xia; Aixin Song; Zhiying Liu; Bin Su; Hui Chen; Yaokai Chen; Hao Wu
Journal:  Front Immunol       Date:  2018-06-26       Impact factor: 7.561

4.  HCV genotype profile in Brazil of mono-infected and HIV co-infected individuals: A survey representative of an entire country.

Authors:  Mariana Fernanda Rodrigues Nutini; James Hunter; Leila Giron; Ana Flavia Nacif Pinto Coelho Pires; Igor Massaki Kohiyama; Michelle Camargo; Maria Cecilia Araripe Sucupira; Adele Schwartz Benzaken; Paulo Abrão Ferreira; Hong-Ha M Truong; Ricardo Sobhie Diaz
Journal:  PLoS One       Date:  2020-01-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.